We are happy to welcome you at the 5th edition of the annual course dedicated to hereditary cardiac diseases, organized by the Romanian Society of Cardiology and the Expert Center for Rare Genetic Cardiac Diseases from the Emergency Institute of Cardiovascular Diseases “Prof.dr.C.C.Iliescu”, together with the University of Medicine and Pharmacy “Carol Davila” Bucharest and the Romanian Society of Cardiology.
After the success of the first 4 editions, we wanted this year’s course to bring updated information from new areas: when and how of the genetic testing, new therapies in genetic cardiomyopathies, new in arrhythmogenic cardiomyopathy, imaging of the hypertrophied heart, channelopathies and athlete’s heart. We also organize a session on how to setup a cardiogenetic center. The program is supported by Romanian and European experts in the field, reflecting the strong collaboration between groups from several European expert centers within the European Refernce Network Guard Heart.
We added at this year’s edition commented cases session, an opportunity for specialists involved in the care of cardiac hereditary diseases to share and discuss their experience with colleagues.
We hope that this meeting becomes a fix date in the agenda of those interested in cardiogenetics in Romania, strengthening their collaboration with the Expert Center for Rare Genetic CV Diseases. Updated information can always be found on the event’s webpage.
Prof. Dr. Ruxandra Jurcuţ
Coordinator – Expert Center for Rare Genetic Cardiovascular Diseases
Prof. Dr. Carmen Ginghină
Editor in Chief of the Romanian Journal of Cardiology
Coordinator of ESC Guidelines in Romania
Prof. Dr. Bogdan A. Popescu
President of the Romanian Society of Cardiology
Past President of the European Association of Cardiovascular Imaging
Chief of the Complex Unit of the Cardiology – Umberto I°Hospital Nocera Inf (ASL Salerno) .
Board member of European reference network ERN Guard-Heart
His Scientific topic is related to the management of the Cardiomyopathies (DCM, HCM, ARVC, LVNC), the identification of the genetic basis and the translational aspects.
Pr Ph. Charron has published numerous original articles in highly rated peer reviewed journals, including coordination or co-authorship of International Guidelines on management of Cardiomyopathies.
Monica Chivulescu, MD, PhD fellow at Department of Cardiology, Oslo University Hospital, Rikshospitalet and University of Oslo.
Monica Chivulescu is a medical doctor and specialist in cardiology with special interest in cardiac imaging. She is certified in transthoracic and transoesophageal echocardiography by the European Association of Cardiovascular Imaging. She works at the Department of Cardiac Ultrasound and at the Outpatient Clinic for Cardiogenetics at Oslo University Hospital, Rikshospitalet.
Graduate of C.D.Loga High School, Timișoara (1986), “Victor Babeș” University of Medicine and Pharmacy: Timișoara (1993); “Diplôme Inter-Universitaire de Stimulation Cardiaque”, Faculté de Médecine de Marseille, Université de la Méditerranée and specialist cardiologist (2001) competence Electrophysiology and Cardiac Stimulators (2003), national responsibility for competence of implantable devices (2018) associate professor Clinic of Cardiology II (2018), University of Medicine and Pharmacy, «Victor Babeș» Timișoara; PhD habilitat - doctoral management qualification certificate (2019); chairman of the SRC Arrhythmias working group (2020)
Lia Crotti is associate professor of Cardiology at the University Milano Bicocca in Milan and she is the head of the Cardiomyopathy Unit in the IRCCS Istituto Auxologico Italiano in Milan, Italy. Furthermore she has a leading role in the Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, directed by Peter J Schwartz.
Lia Crotti is an internationally renowned expert in channelopathies and cardiomyopathies and her research interests are mainly focused on the genetic basis of sudden cardiac death, in genetically transmitted arrhythmogenic diseases, in the Sudden Infant Death Syndrome (SIDS), stillbirths and in more common diseases, such as myocardial infarction. Furthermore, her research is focused on the improvement of the clinical management and treatment of patients affected by arrhythmogenic diseases. She is author or co-author of 152 peer reviewed papers and 19 book chapters. Her total Impact factor is 1210, with a total H-index of 44. Besides her home Country (Italy) she has been spending research periods in the USA, South Africa, and Germany.
Adela Chirita-Emandi is a consultant in Pediatrics and in Medical Genetics, Assistant Professor in the Department of Genetics of the University of Medicine and Pharmacy Victor Babes Timisoara. The experience in research includes more than 30 scientific papers published in national and international journals (including in journals Nature and The Lancet), editor or co-author of 7 books and more than 80 presentations and posters at national and international conferences. She is a Vice president of the Romanian Society of Medical Genetics, and member in the European Society of Medical Genetics ESHG. She is a geneticist in the Regional Center of Medical Genetics Timis within Emergency Hospital for Childre “Louis Țurcanu” Timişoara, a reference center witih European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ITHACA. She is part of the Genomic Medicine Center team, coordinated by Prof Dr Puiu, in the University of Medicine and Pharmacy Victor Babes Timisoara. The main clinical interests are genetics and rare diseases.
Dorica Dan founded APWR (Prader Willi Romania Association) in 2003, initiated in 2007 ANBRaRo (National Alliance for Rare Diseases Romania) and in 2011 the Romanian Association of Rare Cancers. She took part in the opening of the first Information Center on Rare Genetic Diseases in Romania, initiated the National Plan for Rare Diseases in Romania and the NoRo Center - Pilot Reference Center for Rare Diseases NoRo, in Zalau. He is a member of the Board of Directors of EURORDIS (European Organization for Rare Diseases), ambassador IPWSO (International Organization Prader Willi Syndrome, member of CNBR - National Council of Rare Diseases of the Ministry of Health and WHO CGN4RD - WHO Collaborative Global Network for Rare Diseases Program.
MBBS; MD; FRCP; FESC; FACC
Prof. Perry M. Elliott (H-index 101) is Professor of Cardiovascular Medicine at University College London (UCL) and a Senior Investigator of the UK National Institute for Health Research (NIHR). He is director of the UCL Centre for Heart Muscle Disease, Head of Clinical Research at the Institute of Cardiovascular Science UCL and a consultant cardiologist in the Centre for Inherited Cardiovascular Disease at St. Bartholomew's Hospital London, UK. He studied medicine at St. Thomas’s Hospital Medical School, London. He became a full Professor at UCL in 2012.He was elected as a Fellow of the European Society of Cardiology (ESC) in 2005, is Chairman of the ESC Heart Academy, past Chairman of the ESC Working Group on Myocardial and Pericardial Diseases (2010–2012) and the Executive Committee for the European Outcomes Research Programme registry on cardiomyopathies, chair of the ESC Guideline Task Force on Hypertrophic Cardiomyopathy, member of the Congress Programme Committee 2018-2020 and a member of the ESC Managerial Council 2018-2020. He is President of Cardiomyopathy UK, Europe’s foremost charity for patients with heart muscle disease. He is an executive editor for the European Heart Journal.
■ Cardiology resident, year IV within IUBCV "Prof. Dr. C. C. Iliescu", Bucharest;
■ Clinical and research activity, with special interest for genetic heart diseases, at the Center of Expertise for Rare Genetic Cardiovascular Diseases within IUBCV;
■ UMF graduate "Carol Davila", Bucharest with the title -"Cardiovascular damage in Marfan's disease" under the guidance of Prof. Univ. Dr. Ruxandra Jurcuț;
■ Medical personal trainer within the national project PediDiab 2018-2020.
Marianna Fontana is the Director of the UCL CMR unit at the Royal Free Hospital. She is Professor of Cardiology and Honorary Consultant Cardiologist at the National Amyloidosis Centre, University College London, where she is deputy Head of Center for Amyloidosis and Acute Phase Proteins and deputy clinical lead of the National Amyloidosis Center. She obtained her Medical degree (MD) and qualifications as a cardiologist at the University of Pisa. She undertook a PhD at UCL which focused on CMR in cardiac amyloidosis. She was awarded with an intermediate fellowship from the British Heart Foundation in 2018. She has co-authored 168 peer reviewed publications with >8300 citations (h-index 46).
Dan Gaiţă is Board Member of European Society of Cardiology, Board Member of European Heart
Network, Vice President of Romanian Society of Cardiology and President of CardioPrevent
His long term commitment in the field of Cardiovascular prevention is reflected in international
positions and pioneering activities:
- 2006 – 2010 – Member of ESC Education and Accreditation Committee (Chairman of Education and
Accreditation Committee - European Association for Cardiovascular Prevention and Rehabilitation
- since 2009 – initiator and co-director of Dubrovnik Cardiology Update (endorsed by ESC Education
Committee) – 2009/2011/2013/2013/2017/2019 edition
- 2012 - 2015 – Board Member of World Heart Federation
Some of his activitis as lipid expert in Romania are:
- since 2010 – President and Founder of Forum for Prevention ( NCD Alliance )
- since 2016 – Co-director of Lipid School – official course of Romanian Society of Cardiology
- 2016 – initiator of FH screening in 10 years old children
- since 2017 – official EAS representative
- 2018 – Director of EAS Advanced course Clinical Excellence in Lipidology
- since 2021 – National Coordinator for EAS Lipid Clinics Network
Resident cardiologist at the Emergency Institute for Cardiovascular Diseases “Prof. Dr. CC Iliescu ”from Bucharest and doctoral student, with a strong passion for the field of rare genetic cardiovascular diseases, starting on the path of cardiomyopathies since college, when I did my bachelor's thesis on Arrhythmogenic Cardiomyopathy at the Center of Expertise for Genetic Cardiovascular Diseases Rare, under the coordination of Professor Ruxandra Jurcuț. Currently, Mrs. Professor is my mentor, closely supervising my activity and daily practice in the complex process of diagnosis and management of cardiovascular diseases with genetic determinism.
A urmat cursurile Facultăţii de Medicină „Carol Davila” din București - absolvind-o într-un mod strălucit. Şi-a făcut cu deosebită abnegaţie specialitatea de cardiologie. Şi-a perfectat teza de doctorat despre “ Tratamentul fibrinolitic în infarctul miocardic”. A condus Clinica de Cardiologie a Institutului de Urgenţă pentru Boli Cardiovasculare “Prof C.C. Iliescu”, ajutând nenumăraţi bolnavi să-şi depăşească suferinţa şi educând multe generaţii de medici să-şi înşusească cu răbdare şi înţelegere cardiologia.
A fost Preşedintele Societăţii Române de Cardiologie.
Conduce ca Redactor Şef Revista Română de Cardiologie.
Este coordonatorul Ghidurilor ESC pentru România.
A publicat o serie de cărţi (dintre care se reţine „Micul tratat de cardiologie- 2017”) şi mai mult de 100 articole în reviste de prestigiu cu impact asupra întregii lumi medicale.
Primary care cardiologist, doctor of medicine (2010)
Head of Electrophysiology Department (EHRA Recognized Training Center - 2017)
Institute of Cardiovascular Diseases Iasi, “Prof. Dr. George I. M. Georgescu ”
European and national accreditation of electrophysiology (2006) and implantable devices (2009)
Former Chairman of the Working Group on Arrhythmias, Electrophysiology and Implantable Devices of the Romanian Society of Cardiology (2017-2020)
Fellow of the European Society of Cardiology (2003)
Member of the EHRA Selection Committee (2020-2022)
Professor, Head of the Sports Medicine Department at the University of Medicine and Pharmacy “Carol Davila” and Senior Physician Specialist in Sports Medicine at the National Institute of Sports Medicine, Bucharest, Romania; National Coordinator for Sports Medicine Training since 2006; European Trainer on Sports Medicine (UEMS-MJC)) from 2015, Managing Editor of the Romanian Sports Medicine Journal (www.medicinasportiva.ro); President of the Romanian Society of Sports Medicine (2005-present); President of the Balkan Sports Medicine Association (2006-2008)
Advisor for Gatorade Sports Science Institute (2006-2009)
Member of the Scientific and Education Commission of EFSMA (2007-2009)
Member of the Executive Committee of the EFSMA (2009-2017)
President of the Scientific and Education Commission of EFSMA (2017-prezent)
I am focusing my activity on sports physiology and physiopathology, sports cardiology and nutrition, exercise capacity testing in order, EPH ( Exercise prescription for health) to optimize sports performance and promote health.
Dr. Kaski is Associate Professor of Paediatric Inherited Cardiology at the UCL Institute of Cardiovascular Science and Consultant Paediatric Cardiologist at Great Ormond Street Hospital (GOSH), London, UK. He is the Director of the GOSH Centre for Inherited Cardiovascular Diseases, the largest centre in Europe dedicated to the investigation and management of inherited cardiac conditions in childhood. Dr Kaski’s clinical and research interests are focused on the clinical and genetic characterisation of inherited cardiovascular disease and sudden cardiac death in childhood and he won the Young Investigator Award for Clinical Science from the European Society of Cardiology in 2008 for his work on the genetic basis of pre-adolescent hypertrophic cardiomyopathy. He is the current Chair of the Association for European Paediatric Cardiology (AEPC) Working Group on Genetics, Basic Science and Myocardial Disease and sits on the Executive Board of the European Society of Cardiology (ESC) Cardiomyopathy and Myocarditis Registry Programme and the ESC Council on Cardiovascular Genomics. He leads an international paediatric HCM consortium of over 45 centres, which was responsible for the development of the first sudden death risk prediction model for childhood HCM.
Olivier Lairez received his MD and PhD degrees from the Paul Sabatier University in Toulouse, France, in 2008 and 2010, respectively. He has both specialities of cardiologist and nuclear physician. He spent two years from 2012 to 2014 in the Translational and Molecular Imaging Institute, Icahn School of Medicine at mount Sinai, New York, USA, where he did research on atherosclerotic plaque imaging. In 2021, he completed an executive MSc degree in health economics, outcomes and management in cardiovascular sciences (joint collaboration between the European Heart Academy of European Society of Cardiology and London School of Economics).
In 2014, he took a position as associate professor, and since 2018, he has held a position of professor at the Rangueil University Hospital in Toulouse, France. He is currently the head of the Cardiac Imaging Center and the Cardiac Exploration Unit of the Rangueil University Hospital.
Since 2012, he is member of both European Society of Cardiology and European Association of Cardiovascular Imaging. Since 2015, he is a member of the Executive Committee of the Board of Directors of the cardiac imaging subsidiary of the French Society of Cardiology. Since 2018, he is member of the working group on myocardial & pericardial diseases of the European Society of Cardiology.
Dr. Limongelli graduated (1997) and completed his Cardiology Training (2001) from the Second University of Naples (SUN). In 2001, he attended the “Master in Nephrology” (SUN). In 2001, he won a four years PhD course in Cardiovascular and Thoracic Sciences and Associated Biotechnology (SUN).
From 2002 to 2003, he was attached to St George’s Hospital Medical School (London, UK) as Research Fellow of The Genotyping Lab & Heart Failure Clinic. From 2003 to 2004, he was attached to The University College of London (London, UK) as Research Fellow of The Cobbold Lab (Middlesex Hospital) & Heart Failure Clinic (The Heart Hospital). During his stay in St George’s Hospital, he attended a 6 months “Bioinformatics Half Module” at the Department of Basic Sciences. In 2003, he started an “European Doctorate in Biotechnology” course (HeduBT, UK), with a project on “Clinical and Molecular Aspects of Cardiomyopathies”. He was appointed with the title of “European Doctor in Biotechnology” in 2007.
He is currently an Associate professor of Cardiology (since november 2017) at the Department of Translational Science, Università della Campania “Luigi VanvitellI” - Monaldi Hospital (AORN Colli), and Honorary Senior Lecturer (since May 2017) at the the Institute of Cardiovascular Sciences, University College of London, London, UK. His main research interests are clinical and genetic mechanisms of cardiomyopathies and heart failure, congenital, inherited, and rare disease, and athlete’s heart.
Prof. Aleš Linhart, DSc, FESC graduated at Charles University in Prague, Czech Republic. Subsequently he received his training in cardiology and vascular medicine at General University Hospital in Prague and Broussais Hospital in Paris, France. Moving back to the First medical faculty of the Charles University in Prague, he continued his professional career and research focusing mainly on metabolic cardiomyopathies, noninvasive cardiac imaging, and atherosclerosis. In 2004 he was appointed professor at Charles University in Prague. He is currently heading the Department of Cardiovascular Medicine of the First Medical Faculty which hosts the major Center for Fabry disease and Pulmonary Hypertension in the Czech Republic. Prof. Linhart authored or co-authored more than 400 papers and reviews, 58 book chapters and 8 monographs (H-index 44). He is member of several scientific societies, namely Czech and European Society of Cardiology. Currently he holds a position of a chairman the Czech Society of Cardiology.
Cardiologist at the National Institute of Sports Medicine in Bucharest. Sheresided at the Emergency Institute for Cardiovascular Diseases “Prof. Dr. C.C. Iliescu ”, and is currently pursuing a master's degree in imaging in sports cardiology at the University of Siena.
I am dual trained in clinical psychology and genetic counselling and I am currently senior lecturer at Babeș-Bolyai University, Romania and the University of Manchester, UK. My clinical/research/academic experience, in Romania and the UK, gave me an overview of the complexities of different education and healthcare systems. I have been member/co-chair of the Genetic Counselling division of the European Board of Medical Genetics (EBMG), from 2012 until 2020 where I have been actively involved in setting up unified standards for education, practice and registration in genetic counselling throughout Europe.
Prof. Iacopo Olivotto is Head of the Cardiomyopathy Unit and Associate Professor of Cardiovascular Medicine at Careggi University Hospital in Florence, Italy. Over the last two decades, his main clinical and research interests have includes various aspects of cardiomyopathies, with special focus on hypertrophic cardiomyopathy (HCM), ranging from clinical predictors of disease progression and outcome, arrhythmias, medical and surgical management, advanced imaging and genetic studies, developmental, translational studies addressing cardiac myofilament contractility and cellular electrophysiology. These lines of research have been instrumental in creating a growing multidisciplinary network connecting the Florence team to distinguished Institutions worldwide. Prof. Olivotto has been involved in the design and execution of randomized studies in genetic cardiomyopathies, and has been the lead of the recently presented Explorer HCM trial. Prof. Olivotto has co-authored over 200 papers in international, peer-reviewed journals. He is a co-founder and board member of The Sarcomeric Human Cardiomyopathy Registry (Share) and ICON (International CardiomyOpathy Network).
Cardiologist, with European certification of level 3 in cardiovascular magnetic resonance, competence in transesophageal echocardiography.
Head of UMF works Carol Davila, Dr. Sebastian Onciul specializes in non-invasive imaging diagnosis of cardiovascular diseases. He received a scholarship from the European Society of Cardiology to train for a year in the UK in the field of cardiovascular magnetic resonance imaging. He is a member of the European Society of Cardiovascular Imaging and co-editor of the Pocket Guide to Cardiovascular Magnetic Resonance Imaging of the European Society of Cardiology (ESC) / European Society of Cardiovascular Imaging (EACVI).
MBBS, MD, MRCP, FESC
Dr Papadakis is a Reader (Assoc Professor) in Cardiology at St George’s, University of London and an Honorary Consultant Cardiologists at St George’s University Hospitals. Dr Papadakis qualified at Imperial College School of Medicine in London in 2001 and gained membership of the Royal College of Physicians in 2007. In 2014 he was awarded a Medical Doctora at King’s College London. He is the president-elect for the European Association of Preventive Cardiology (EAPC) and the past-chair of the section of Sports Cardiology and Exercise of the EAPC. His interests include sports cardiology, inherited cardiac diseases, cardiovascular disease prevention including prevention of sudden cardiac death in young and athletic individuals, heart failure and cardiac imaging. Dr Papadakis is currently credited with more than 80 publications in peer reviewed medical journals and numerous presentations in national and international conferences. He has contributed to a number of projects as an expert, including the creation of the Sports Cardiology core curriculum, the creation of the international ECG criteria for an athlete’s evaluation and exercise guidelines in individuals with heart disease. He has advanced education in the field of Sports Cardiology by building educational material for the European Society of Cardiology and launching a novel MSc degree in Sports Cardiology, the first postgraduate qualification of its kind.
Dr. García-Pavia is a Consultant cardiologist at the Department of Cardiology of Hospital Universitario Puerta de Hierro in Madrid, Spain. There he is in charge of the Inherited Cardiac Diseases and Heart Failure Unit. The Unit is designed as national reference unit (CSUR) for inherited cardiovascular diseases by the Spanish Ministry of Health and also acts as a European reference center for rare cardiovascular diseases after its designation by the European Comission.
His areas of research include heart failure, amyloidosis and cardiomyopathies. After finishing his training in Cardiology in Madrid, Dr Garcia-Pavia completed a clinical research fellowship at the Inherited Cardiovascular Diseases Unit at The Heart Hospital (University College of London) in London, UK. Previously he had undertaken short stays as research fellow in basic research labs focused in genetics at the University of Chicago, Complutense University and Autonoma University.
Dr Garcia-Pavia is the leader of the 2021 ESC position paper on diagnosis and treatment of cardiac amyloidosis and serves in the steering committee of several ongoing clinical trials in TTR cardiac amyloidosis and genetic cardiomyopathies. He is also former member of ESC Council on Basic Research, former member of the Nucleus of ESC working group on myocardial and pericardial diseases, and former president of Spanish Society of Cardiology’s working group on inherited cardiac diseases. He has published >160 articles in peer-reviewed journals including European Heart Journal, J Am Coll Cardiol, Circulation, Nature Communications, Nature Medicine and The Lancet.
Bogdan A. Popescu is Professor of Cardiology at the University of Medicine and Pharmacy "Carol Davila" in Bucharest, Romania. He is Head of cardiology department and director of the echocardiography laboratory at the Institute of Cardiovascular Disease "Prof. C. C. Iliescu" in Bucharest.
He published more than 180 scientific papers in peer-reviewed journals and more than 25 book chapters and books in cardiology and cardiac imaging. His main fields of research interest are on myocardial function/heart failure, cardiomyopathies, valvular heart disease.
He is Immediate Past-President of the European Association of Cardiovascular Imaging (2018-2020) and President Elect of the Romanian Society of Cardiology (2017-2020).
University professor, PhD supervisor, Victor Babeş University of Medicine and Pharmacy, Timişoara
Primary Care Pediatrician, Primary Care Physician Medical Genetics
Coordinator of the Center for Genomic Medicine
Coordinator of the Department of Medical Genetics of the Emergency Clinical Hospital for Children L. Turcanu, Timişoara
Chief physician of the Timiș Regional Center for Medical Genetics
Former President of the Romanian Society of Medical Genetics,
Founding member and Vice President of the National Alliance for Rare Diseases,
President of the National Council for Rare Diseases
Editor-in-Chief of the Romanian Journal of Rare Diseases
Scientific coordinator of the E-University of Rare Diseases
Director and / or member of the research team in numerous research projects (the last one, worth over 5 million euros, ensured the creation of the research infrastructure of the Center for Genomic Medicine).
Coordinator and / or author, co-author of over 35 monographs, books, guides, courses and over 300 papers published in magazines in the country or abroad
Studies:1984-2000 MD, Faculty of General Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
Scientific positions/titles: PhD “Carol Davila” University of Medicine, Bucharest (2016); Lecturer, “Carol Davila” University of Medicine, Bucharest (2016)
Professional experience 2001-2007 Resident in Cardiology at “Prof. Dr. C.C. Iliescu” Institute of Cardiovascular Diseases, Bucharest; 2008 Specialist Cardiologist at “Prof. Dr. C.C. Iliescu” Institute of Cardiovascular Diseases, Bucharest; 2015 Head of Stress echocardiography department, EuroEcolab, Echocardiography laboratory of “Carol Davila”University of Medicine, reaccreditation in TTE, TOE, Stress echocardiography in Jan 2015; 2016 Senior Cardiologist at “Prof. Dr. C.C. Iliescu” Institute of Cardiovascular Diseases, Bucharest
Certification/Accreditation: National certification in vascular ultrasonography (2009); Certification in stress echocardiography (Liege, Belgium, 2010); European certification in transthoracic echocardiography (by exam, Amsterdam, 2013); National certification in special echocardiography (including TEE and stress echocardiography; since 2014)
Fellowships: 2007 Research Fellowship in cardiology, awarded by The Association for Research in Cardiology, Pordenone, Italy (1 year); 2009 Research Fellowship in cardiology, awarded by The Romanian Society of Cardiology (fellowship in stress echocardiography, Belgium, Liege – 1 year)
Publications and scientific activities: 35 full-text articles published in journals indexed by ISI-Science Citation Index; Hirsch Index: 18 by ISI Thomson; more than 1100 ISI citations; Author of 11 book chapters; Author of a book chapter in the EACVI Textbook on echocardiography (2016); Invited speaker at the Romanian Congress of Cardiology (since 2006), Congress of the European Association of Cardiovascular Imaging (EACVI) (since 2012), The XIX World Congress of Echocardiography and Allied Techniques (2014); Member in the project team of international multicenter studies (NORRE, SUCCOUR, ISCHEMIA, COT Registry – EORP, EUROENDO Registry, EACVI AFib Echo Europe Registry, EMPEROR) and National research grants; Member of the peer-review committee (Cardiovascular Ultrasound and Acta Cardiologic)
Alina Scridon is Professor of Physiology at the University of Medicine, Pharmacy, Science and Technology “George Emil Palade” of Târgu Mureș, Coordinator of the Functional Explorations Laboratory of the Center for Advanced Medical and Pharmaceutical Research and of the Cardiovascular Physiology and Pathophysiology Laboratory Târgu Mureș, and President of the Experimental Cardiology Working Group of the Romanian Society of Cardiology.
Primary Cardiologist at the Institute of Cardiovascular Diseases "Prof. Dr. George I.M. Georgescu ”Iași
Associate Professor at the University of Medicine and Pharmacy "Grigore T. Popa" Iasi The head of the Cardiology Clinic within the Institute of Cardiovascular Diseases “Prof. Dr. George I.M. Georgescu ”Iași
European Competence in Implantable Cardiac Devices
Dr. Svetlana Stoica, cardiologist at the Institute of Cardiovascular Diseases Timisoara in the Research Department, has a rich experience in clinical trials. She is currently a PhD student at the Victor Babeș University of Medicine and Pharmacy in Timișoara, as well as an associate professor.
Medic Primar Cardiologie şi Medicină Internă
Absolvent al Facultăţii de Medicină şi Farmacie Carol Davila Bucureşti 1997
Cadru universitar al Facultăţii de Medicină şi Farmacie Carol Davila Bucureşti 2000 (conferenţiar din 2019)
Coordonator naţional al competenţei de Electrofiziolgie Interventională (din 2018). Membru al comisiei de acreditare a EHRA pentru Electrofiziolgie Interventională (din 2020)
Fost presedinte al GLA al SRC (2011-2014), membru al nucleului GLA (din 2008), membru al board-ului SRC (din 2020)
Interes particular: tratamentul ablativ al aritmiilor complexe (fibrilaţie atrială, aritmii pericatriceale, aritmii pe fond de cardiopatii congenitale, aritmii ventriculare complexe pe cord cu afectare structurală), terapie de resincronizare cardiac şi alte metode speciale de stimulare cardiacă (stimulare His si de ram stâng, leadless, wireless etc).
Prof. Dr. Arthur A.M. Wilde got his M.D. at the University of Amsterdam in 1983 and was registered as a Cardiologist in 1994 and electrophysiologist in 1996.
Between 2003 and 2020 he served as head of the Department of Clinical and Experimental Cardiology (Academic Medical Centre) and between 2012 and 2019 as Chair of the Heart Centre Division, AMC. He published over 600 SCI papers with a major focus on different aspects of inherited arrhythmia syndromes.
In 2011 he was appointed as member of the Dutch Academy of Science and in 2012 he received the Distinguished Investigator award of the Heart Rhythm Society. Since 2017 he leads the European Research Network (ERN) GUARD-heart on inherited diseases of the heart.
1. Insuficiență cardiacă agravată de beta blocante. Poate aceasta sugera etiologia? Heart failure aggravated by beta blockers. Could this suggest the etiology? Robert Adam*, Andreea Jercan, Sorina Badelita, Ana Fruntelata, Radu Ciudin, Bogdan A Popescu, Carmen Ginghina, Mirela Draghici, Claudiu Stan, Daniel Coriu, Ruxandra Jurcut (IUBCV “Prof.dr.C.C.Iliescu”, Bucuresti);
2. Utilitatea mapei T1 și a evaluarii volumului extracelular prin cardioRM în cardiomiopatile ereditare. The use of T1-mapping and extracellular volume using CMR in inherited cardiomyopathies. Ramona Bică*, Virgil Ionescu (Spitalul Metropolitan-Monza, București)
3. Conturarea unui fenotip specific la rezonanță magnetică cardiovasculară al cardiomiopatiei aritmogene izolate de ventricul stâng secundară mutațiilor genei desmoplakinei. Defining a specific cardiovascular magnetic resonance phenotype in isolated left ventricular arrhythmogenic cardiomyopathy due to desmoplakin mutations. Sebastian Onciul*, Robert Adam, Adrian Giucă, Radu Nicolaescu, Răzvan Capșa, Ruxandra Jurcuț (Spitalul de Urgenţă)
4. Cardiomiopatia dilataivă: de la diagnosticul uzual la surpiza testării genetice. Dilated cardiomyopathy: from the common diagnosis to the surprisis of genetic testing. Robert Adam*, Ionut Stanca, Sebastian Onciul, Viorica Rădoi, Bogdan Alexandru Popescu, Ruxandra Jurcut (IUBCV “Prof.dr.C.C.Iliescu”, Bucuresti;)
5. Cardiomiopatia hipertrofică obstructivă. O mască a bolii Fabry? Obstructive hypertrophic cardiomyopathy – a mask for Fabry disease? Sebastian Militaru*, Robert Adam, Radu Trimbitasu, Ruxandra Jurcut (IUBCV “Prof.dr.C.C.Iliescu”, Bucuresti)
6. Un defect nu vine niciodata singunr. Câte anomalii descoperite întâmplător poate ascunde o singură inimă? A defect never comes alone. How many anomalies discovered by chance can hide a single heart? Robert Adam*, Alina Nicula, Sidonia Albu, Bogdana Fetecău, Carmen Ginghină, BA Popescu, Ruxandra Jurcuț (IUBCV “Prof.dr.C.C.Iliescu”, Bucuresti)
7. Afectarea cardiacă în bolile lizozomale – serie de cazuri. Cardiac manifestations in lysosomal storage diseases – case series. Lazea C.*, Al-Khzouz C., Bucerzan S.,Nascu I., Asavoaie C., Grigorescu-Sido P (UMF „Iuliu Hatieganu”, Clinica Pediatrie I Cluj-Napoca;)
8. Un caz de cardiomiopatie hipertrofică severă în cadrul unei boli metabolice. A case of severe hypertrophic cardiomyopathy as clinical feature of metabolic disease. Lazea C*, Al-Khzouz C, Oprița S, Popa A, Vințan M (UMF „Iuliu Hatieganu”, Clinica Pediatrie I Cluj-Napoca;)
9. CMHO, hipertensiunea arterială grad III, SASO și boala multivasculară la pacientul vârstnic. HOCM, hypertension grade III, OSAS and multivascular disease in elderly patient. Cristiana Drăgănescu*, Octavian Zară, Cornelia Voiculeț, Ruxandra Jurcuț, Alice Bălăceanu (Spitalul Clinic de Urgenţă “Sf.Ioan” Bucureşti;)
10. Cardiomiopatia dilatativă- importanța diagnosticului diferențial. Dilated cardiomiopathy – the importance of differential diagnosis. Laura Țăpoi*, Carina Ureche, Alexandra Clement, Ștefan Boca, Radu Andy Sascău, Cristian Stătescu (Institutul de Boli Cardiovasculare “Prof. Dr. George I.M. Georgescu”, Iaşi, Romania;)
11. Impactul exercițiului fizic în cardiomiopatia aritmogenă de ventricul drept. Impact of physical exercise in arrhythmogenic right ventricular cardiomyopathy – a case report. C. Ureche*, Ș. Ailoaei, L. Țăpoi, A. Clement, A. Cazacu, R. A. Sascău, C. Stătescu (Institutul de Boli Cardiovasculare “Prof. Dr. George I.M. Georgescu”, Iaşi, Romania);
12. Privind dincolo de hipotensiunea ortostatică – un caz interesant de ATTR. Looking beyond orthostatic hypotension – an interesting case of TTR amyloidosis. C. Ureche*, Ș. Ailoaei, L. Țăpoi,A. Clement, A. Cazacu, R. A. Sascău, C. Stătescu (Institutul de Boli Cardiovasculare “Prof. Dr. George I.M. Georgescu”, Iaşi, Romania);
13. Non-compactare de ventricul stang cu fractie de ejectie redusa versus prezervata -fenotipuri diferite, ce ne ofera imagistica multimodala? Left ventricular non-compaction with reduced versus preserved ejection fraction-different phenotypes, what does multimodality imaging offer? Ionela-Simona Visoiu*, Roxana Cristina Rimbaş, Dragos Vinereanu (Spitalul Universitar de Urgenta Bucureşti);
14. Cardiomiopatie aritmogenă – dublă mutație idetificată la un pacient tânăr, sportiv de performanță. Arrhythmogenic Cardiomyopathy – Double Mutation Identified in a Young Athlete. Adrian Giucă*, Rodica Ploeșteanu, Sebastian Onciul, Alin Nicolescu, Ruxandra Jurcuț (IUBCV “Prof.dr.C.C.Iliescu”, Bucuresti);
15. Insuficiență cardiacă la un pacient tânăr cu cardiomiopatie hipertrofică nonobstructivă duce la diagnostic de boală neuromosculară. Heart failure in a young patient with nonobstructive hypertrophic cardiomyopathy leads to a neuromuscular disease diagnosis. Adrian Giucă*, Cristina Mitu, Alexandra Bastian, Bogdan Ovidiu Popescu, Răzvan Capşa, Viorica Rădoi, Claudiu Stan, Bogdan Alexandru Popescu, Ruxandra Jurcuţ (IUBCV “Prof.dr.C.C.Iliescu”, Bucuresti);
16. Amiloidoză cardiacă ereditară cu debut tardiv – mutație genetică particulară. Late-onset hereditary cardiac amyloidosis – peculiar genetic mutation. Ana-Maria Buburuz, Adrian Gavrilescu, Ana-Maria Stătescu, Antoniu Petriș, Daniela Crișu, Spitalul Clinic Județean de Urgență ”Sf. Spiridon” Iași
How you transform your business as technology, consumer, habits industry dynamic s change? Find out from those leading the charge.